id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_vxmcfv7exrbvvpz42zh25a7guy	Sukhuma Warrasak	Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure	2018.0	16	.pdf	application/pdf	9217	987	64	clinical trial for Plasmodium vivax malaria radical cure Including one patient who had decreased sensitivity in the left eye at Day 90 and retinal findings in the left eye on Day 28 Decreased sensitivity on visual field testing was observed at Day 28 in both eyes and was normal at other patient, for whom retinal pigment epithelium alterations in the left eye were seen clinically as a group of vivax malaria patients receiving tafenoquine; corneal changes vivax malaria patients treated with tafenoquine monotherapy or chloroquine/primaquine sequential therapy at each assessment NB: The patient in the chloroquine/primaquine group with baseline bilateral retinal dot hemorrhage is included in this table of results Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure	./cache/work_vxmcfv7exrbvvpz42zh25a7guy.pdf	./txt/work_vxmcfv7exrbvvpz42zh25a7guy.txt